Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Are there studies looking at Ra-223 and SBRT for oligometastatic disease in the setting of mCRPC?
Answer from: Radiation Oncologist at Community Practice
Yes, quite a few including one from UCLA- NCT05496959
Sign in or Register to read more
18046
Related Questions
Do you need renal biopsy before SBRT for RCC suspicious cancer?
How do you manage bladder spasms during pelvic radiotherapy?
Are patients with MIBC and bladder neck involvement good candidates for bladder preservation with chemoradiation after maximal, but not complete, TURBT?
Which patients with prostate cancer do you consider to be good candidates for salvage local treatment after radiation therapy?
Would you treat a patient with evidence of prostate cancer who refuses biopsy?
How would you plan sequencing of an MRI-directed prostate nodule micro-boost when doing a sequential plan?
If using 26-fraction moderate hypofractionation, what dose do you use for the intraprostatic dominant nodule SIB?
Which genomic test do you choose for a patient with favorable intermediate prostate cancer trying to decide between active surveillance and treatment?
Is there evidence that prostatectomy improves overall survival in local recurrence of prostate cancer post-definitive radiation?
Is REZUM (water vapor thermotherapy for BPH) safe after EBRT?